Friendship Bench support for women who use methamphetamine in Vietnam

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The team will adapt the Friendship Bench, a lay worker-delivered mental health intervention, to the needs of women who use methamphetamine in Haiphong, Vietnam. After adaptation, they will run a two-arm randomized trial comparing the adapted Friendship Bench to usual psychiatric care to measure feasibility, fidelity, acceptability, and preliminary signals of impact on common mental disorder symptoms and methamphetamine use. Adult women with moderate-or-greater meth use risk and moderate-or-greater CMD symptoms will be enrolled, while those with severe psychotic disorders or other conditions needing specialty care will be excluded. Findings will provide preliminary data to support a larger R01 effectiveness trial if results are promising.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult women (\>=18 years old)
* Moderate or greater risk for meth use (ASSIST ≥ 4)
* Moderate or greater CMD symptom severity (Depression ≥ 10, Anxiety ≥ 8, and/or Stress ≥ 15 on DASS-21)

Exclusion Criteria:

* Severe psychotic disorders or other interfering problems that require specialty care;
* Inability to understand study procedures by the research team's judgment.

Where it's running

• Friendship Bench & Lighthouse
  Haiphong, Hai Phong, Vietnam Recruiting

Study contacts

• Study coordinator: Trang Thu Nguyen, PhD
• Email: trangthu@hmu.edu.vn
• Phone: +84 988 424 871

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Online cognitive behavior therapy for common mental disorders in primary care

  This study is testing whether online cognitive behavior therapy can help adults with common mental health issues feel better compared to regular care they usually receive.

  Recruiting Karolinska Institutet · Gustavsberg, Stockholm County · NCT06804941

• Community peer support for screening methamphetamine-related heart failure

  This study is testing a new way to help people in rural areas who have heart failure from methamphetamine use by connecting them with peer support and cardiology care.

  Recruiting Oregon Health and Science University · Portland, Oregon · NCT06461962

• Tirzepatide for methamphetamine use disorder (phase 2)

  This phase 2 trial tests whether weekly tirzepatide injections can help adults with moderate to severe methamphetamine use disorder reduce use and improve outcomes compared with placebo.

  Recruiting Phase 2 University of Texas Southwestern Medical Center · Los Angeles, California and 3 other locations · NCT07825857

• Psilocybin Therapy for MeUD and HIV

  This study tests whether a single psilocybin dose, paired with motivational support therapy, can help people with HIV and moderate-to-severe methamphetamine use disorder stop using methamphetamine.

  Recruiting Phase 2 University of California, San Francisco · San Francisco, California · NCT07756736

• ECG changes in adults using methamphetamine with and without psychosis

  This project will see if heart ECG measurements differ between adults hospitalized for methamphetamine use who have psychosis and those who do not.

  Recruiting Elazığ Mental Health and Diseases Hospital · Elâzığ, Elâzığ · NCT07459244

• Benefits of reducing methamphetamine use

  This study will try contingency management to see if cutting back on methamphetamine improves physical, mental, and social health for adults with moderate-to-severe methamphetamine use disorder.

  Recruiting University of Kentucky · Lexington, Kentucky · NCT07226596

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.